A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 950 participants.

Also called NCT02796157

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 950 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02796157
Other papers using this trial's data
  • Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings The American journal of cardiology, 2020-06-01 DOI, PubMed 32279841

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02796157. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
Intervention (Device)
PCI (percutaneous coronary intervention) with Absorb everolimus-eluting bioresorbable vascular scaffold
Intervention (Device)
PCI with Xience everolimus-eluting metallic stent
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct02796157
Content hash
5e9e0c8c1b69f26505609ce484dc821dc5e1119d412b71c903e1929bf049090a